Kayla Ponder to alpha 1-Antitrypsin
This is a "connection" page, showing publications Kayla Ponder has written about alpha 1-Antitrypsin.
Connection Strength
0.486
-
Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy. Blood. 1997 Feb 15; 89(4):1254-9.
Score: 0.130
-
Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum Gene Ther. 1996 Mar 20; 7(5):637-45.
Score: 0.122
-
Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A. 1991 Feb 15; 88(4):1217-21.
Score: 0.086
-
Retroviral vector sequences may interact with some internal promoters and influence expression. Hum Gene Ther. 1996 Jan 20; 7(2):159-71.
Score: 0.030
-
Optimization of liver-directed retroviral gene delivery. Transplant Proc. 1994 Dec; 26(6):3379-80.
Score: 0.028
-
Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood. 1994 Nov 15; 84(10):3394-404.
Score: 0.028
-
Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci U S A. 1994 Feb 15; 91(4):1460-4.
Score: 0.026
-
Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A. 1992 Jan 01; 89(1):89-93.
Score: 0.023
-
Liver-directed gene therapy: evaluation of liver specific promoter elements. J Surg Res. 1994 Jun; 56(6):510-7.
Score: 0.007
-
Human gene therapy: present and future. Breast Cancer Res Treat. 1992; 21(2):83-93.
Score: 0.006